At around 11:48 am, shares of the life insurance company traded down by 1 per cent at Rs 1,042.4 per share on the BSE.
Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...
Discover the HDFC Life Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of HDFC Life with the latest details, including: Last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results